CATEGORIE
Menu
Anti-Cardiovascular Inhibitors
| API | Intermediate | CAS nr. |
Edoxaban | Edoxaban (free base) | 480449-70-5 |
| (1S,3R,4R)-3-(Boc-amino)-4-hydroxy-cyclohexanecarboxylic acid ethyl ester | 365997-33-7（A4） | |
| Carbamic acid, N-[(1R,2R,5S)-5-[(dimethylamino)carbonyl]-2-[(methylsulfonyl)oxy]cyclohexyl]-, 1,1-dimethylethyl ester | 929693-31-2（A7） | |
| tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate | 365998-36-3 (A9) | |
| tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | 1210348-34-7 (A10) | |
| 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | 720720-96-7 (B) | |
| 4,5,6,7-Tetrahydro-5-methylthiazolo[5,4-c]pyridine-2-carboxylic acid | 758685-72-2 (B free base) | |
| 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 (C) | |
| N-(5-Chloropyridin-2-yl)oxalamic acid ethyl ester | 349125-08-2 (C free base) | |
Apixaban | 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 536760-29-9 |
| 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone | 1267610-26-3 | |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 | |
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 | |
| Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 | |
| Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate | 536759-91-8 | |
| Ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503615-07-4 | |
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 | |
Labetalol Hydrochloride | 5-Acetylsalicylamide | 40187-51-7 |
| 5-Bromoacetyl salicylamide | 73866-23-6 | |
| 5-(N,N-Dibenzylglycyl)salicylamide | 30566-92-8 | |
| 2-Hydroxy-5-(2-(4-phenylbutan-2-ylamino)acetyl)benzamide hydrochloride | 96441-14-4 | |
Tolvaptan | 2-Methyl-4-(2-methylbenzoylamino)benzoic acid | 317374-08-6 |
| 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 160129-45-3 | |
| 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one | 137982-91-3 | |
Losartan | 2-Chlorobenzonitrile (OCBN) | 873-32-5 |
| 2-Cyano-4′-methylbiphenyl (OTBN) | 114772-53-1 | |
| 4′-Bromomethyl-2-biphenylcarbonitrile (Br-OTBN) | 114772-54-2 | |
| 2-Butyl-4-chloro-5-formylimidazole (BCFI) | 83857-96-9 | |
Olmesartan | N-(Triphenylmethyl)-5-(4′-bromomethylbiphenyl-2-yl-)tetrazole (BBTT) | 124750-51-2 |
| 4-Chloromethyl-5-methyl-1,3-dioxol-2-one (DMDO-CL) | 80841-78-7 | |
| Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate | 144689-93-0 |
Ophthalmic Remedy Inhibitors
| API | Intermediate | CAS nr. |
Lifitegrast | 5,7-Dichloro-3,4-dihydro-2,6(1H)-isoquinolinedicarboxylic acid 2-(1,1-dimethylethyl) ester | 851784-82-2 |
| 2-tert-butyl 6-methyl 5,7-dichloro-3,4-dihydroisoquinoline-2,6(1H)-dicarboxylate | 851784-80-0 | |
| methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate;hydrochloride | 851784-90-2 | |
| 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride | 1289646-93-0 | |
| 3-(Methylsulfonyl)-L-phenylalanine methyl ester hydrochloride | 851785-21-2 | |
| N-[(1,1-Dimethylethoxy)carbonyl]-3-(methylsulfonyl)-L-phenylalanine | 1289646-76-9 | |
| 3-(Methylsulfonyl)-L-phenylalanine phenylmethyl ester hydrochloride (1:1) | 1194550-59-8 | |
| 6-Benzofurancarboxylic acid | 77095-51-3 | |
Brinzolamide | 3-Acetyl-5-chloro-2-thiophenesulfonamide | 160982-10-5 |
| 3-(2-Bromoacetyl)-5-chloro-2-thiophenesulfonamide | 160982-11-6 | |
| (S)-3,4-dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide | 160982-16-1 | |
| (S)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-4-ol-6-sulfonamide-1,1- dioxide | 154127-42-1 |
Anti-Respiratory Inhibitors
| API | Intermediate | CAS nr. |
Montelukast Sodium | 3-Bromo-2,2-bis(bromomethyl)propanol / Pentaerythritol tribromide | 1522-92-5 |
| 3-bromo-2,2-bis(bromomethyl)propyl acetate | NA | |
| 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid | 162515-68-6(B3) | |
Indacaterol | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | 312753-53-0 |
| 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | 100331-89-3 | |
| (R)-8-(benzyl)-5-(oxiran-2-yl) quinolin-2(1H)-one | 173140-90-4 | |
| (R)-(+)-2-Methyl-CBS-oxazaborolidine | 112022-83-0 | |
Tezacaftor VX-661 | 2-Bromo-5-fluoro-4-nitroaniline | 952664-69-6 |
| (R)-benzylglycolated-4-ammonium-2-bromo-5-fluoroaniline tosylate salt | 1294504-64-9 | |
| (S)-(2,2-Dimethyl-1,3-dioxolan-4-yl) methyl-4-methyl benzenesulfonate | 23735-43-5 | |
| (((2,2-dimethylbut-3-yn-1-yl)oxy)methyl)benzene | 1092536-54-3 (N-5) | |
| (R)-1-(5-Amino-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-1-yl)-3-(benzyloxy) propan-2-ol | 1294504-67-8 | |
| 2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-5-nitro-1H-indole | 1638771-94-4 |
Anti-Cancer Inhibitors
| API | Intermediate | CAS nr. |
VenetoclaxABT-199 | 4-Fluoro-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzoic acid methyl ester | 1235865-75-4 |
| methyl 2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-(piperazin-1-yl)benzoate | 1257044-57-7 | |
| 3-Nitro-4-[(oxan-4-ylmethyl)amino]benzene-1-sulfonamide | 1228779-96-1 | |
| 1-Piperazinecarboxylic acid, 4-[3-fluoro-4-(methoxycarbonyl)phenyl]-, 1,1-dimethylethyl ester | 1121599-68-5 | |
| 1-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazine dihydrochloride | 1628047-87-9 | |
| 1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine | 1228780-72-0 | |
| [2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methanol | 1228780-51-5 | |
| 5-Hydroxy-7-azaindole | 98549-88-3 | |
| 5-Bromo-7-azaindole | 183208-35-7 | |
Ibrutinib | Ethoxymethylenemalononitrile | 123-06-8 |
| 4-Aminopyrazolo[3,4-d]pyrimidine | 2380-63-4 | |
| 4-Amino-3-iodopyrazolo[3,4-d]pyrimidine | 151266-23-8 | |
| 3-Amino-1H-4-cyanopyrazole | 16617-46-2 | |
| 3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine | 83255-86-1 | |
Upadacitinib ABT 494 | Upadacitinib | 1310726-60-3 |
| 3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1428243-26-8 | |
| (3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester compd. with (alphaR)-alpha-methyl-1-naphthalenemethanamine (1:1) | 1428243-25-7 | |
| 5-[(4-methylphenyl)sulfonyl]-5H-Pyrrolo[2,3-b]pyrazin-2-amine | 1201187-46-3 | |
| tert-butyl (5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)carbamate | 1201187-44-1 | |
Temozolomide | Temozolomide | 85622-93-1 |
| 5-Amino-4-imidazolecarboxamide (AICA) | 360-97-4 | |
| 4-Amino-5-imidazolecarboxamide hydrochloride (AICA HCl) | 72-40-2 | |
Gadobutrol | Gadobutrol | 138071-82-6 |
| Cyclen/1,4,7,10-Tetraazacyclododecane | 294-90-6 | |
| 4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane | 57280-22-5 |
Anti-Diabetic Inhibitors
| API | Intermediate | CAS nr. |
Dapagliflozin
Empagliflozin | 5-Bromo-2-chlorobenzoic acid | 21739-92-4 |
| 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether | 461432-23-5 | |
| (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone | 461432-22-4 | |
| (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan | 915095-89-5 | |
| 2-(5-Bromo-2-fluorobenzyl)benzothiophene | 1034305-17-3 | |
Gliclazide | Gliclazide(API) | 21187-98-4 |
| 4-Toluenesulfonylurea | 1694-06-0 | |
| Cyclopentane-1,2-dicarboximude | 5763-44-0 | |
| 3-Azabicyclo[3.3.0]octane hydrochloride | 112626-50-3 | |
| N-Amino-3-Azabicyclo[3,3,0]-Octan Hcl | 58108-05-7 |
Anti-Inflammatory Inhibitors
| API | Intermediate | CAS nr. |
Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | 160844-75-7(F5) |
| Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2(F3) |
Anti-Psychotic Inhibitors
| API | Intermediate | CAS nr. |
Lurasidone Hydrochloride | (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione | 14805-29-9 |
| Cis-5-Norbornene-exo-2,3-dicarboxylic anhydride | 2746-19-2 | |
| (1R,2R)-1,2-Cyclohexanedimethanol | 65376-05-8 | |
| (1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid | 46022-05-3 | |
| 4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl]piperazin-1-ium-1-sulfonate | 186204-37-5 |
| Edoxaban | Edoxaban (free base) | 480449-70-5 |
| Edoxaban | (1S,3R,4R)-3-(Boc-amino)-4-hydroxy-cyclohexanecarboxylic acid ethyl ester | 365997-33-7（A4） |
| Edoxaban | Carbamic acid, N-[(1R,2R,5S)-5-[(dimethylamino)carbonyl]-2-[(methylsulfonyl)oxy]cyclohexyl]-, 1,1-dimethylethyl ester | 929693-31-2（A7） |
| Edoxaban | tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate | 365998-36-3 (A9) |
| Edoxaban | tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | 1210348-34-7 (A10) |
| Edoxaban | 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | 720720-96-7 (B) |
| Edoxaban | 4,5,6,7-Tetrahydro-5-methylthiazolo[5,4-c]pyridine-2-carboxylic acid | 758685-72-2 (B free base) |
| Edoxaban | 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 (C) |
| Edoxaban | N-(5-Chloropyridin-2-yl)oxalamic acid ethyl ester | 349125-08-2 (C free base) |
| Apixaban | 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 536760-29-9 |
| Apixaban | 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone | 1267610-26-3 |
| Apixaban | 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 |
| Apixaban | 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 |
| Apixaban | Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 |
| Apixaban | Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate | 536759-91-8 |
| Apixaban | Ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503615-07-4 |
| Apixaban | 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 |
| Labetalol Hydrochloride | 5-Acetylsalicylamide | 40187-51-7 |
| Labetalol Hydrochloride | 5-Bromoacetyl salicylamide | 73866-23-6 |
| Labetalol Hydrochloride | 5-(N,N-Dibenzylglycyl)salicylamide | 30566-92-8 |
| Labetalol Hydrochloride | 2-Hydroxy-5-(2-(4-phenylbutan-2-ylamino)acetyl)benzamide hydrochloride | 96441-14-4 |
| Tolvaptan | 2-Methyl-4-(2-methylbenzoylamino)benzoic acid | 317374-08-6 |
| Tolvaptan | 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 160129-45-3 |
| Tolvaptan | 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one | 137982-91-3 |
| Losartan | 2-Chlorobenzonitrile (OCBN) | 873-32-5 |
| Losartan | 2-Cyano-4′-methylbiphenyl (OTBN) | 114772-53-1 |
| Losartan | 4′-Bromomethyl-2-biphenylcarbonitrile (Br-OTBN) | 114772-54-2 |
| Losartan | 2-Butyl-4-chloro-5-formylimidazole (BCFI) | 83857-96-9 |
| Olmesartan | N-(Triphenylmethyl)-5-(4′-bromomethylbiphenyl-2-yl-)tetrazole (BBTT) | 124750-51-2 |
| Olmesartan | 4-Chloromethyl-5-methyl-1,3-dioxol-2-one (DMDO-CL) | 80841-78-7 |
| Olmesartan | Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate | 144689-93-0 |
| Lifitegrast | 5,7-Dichloro-3,4-dihydro-2,6(1H)-isoquinolinedicarboxylic acid 2-(1,1-dimethylethyl) ester | 851784-82-2 |
| Lifitegrast | 2-tert-butyl 6-methyl 5,7-dichloro-3,4-dihydroisoquinoline-2,6(1H)-dicarboxylate | 851784-80-0 |
| Lifitegrast | methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate;hydrochloride | 851784-90-2 |
| Lifitegrast | 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride | 1289646-93-0 |
| Lifitegrast | 3-(Methylsulfonyl)-L-phenylalanine methyl ester hydrochloride | 851785-21-2 |
| Lifitegrast | N-[(1,1-Dimethylethoxy)carbonyl]-3-(methylsulfonyl)-L-phenylalanine | 1289646-76-9 |
| Lifitegrast | 3-(Methylsulfonyl)-L-phenylalanine phenylmethyl ester hydrochloride (1:1) | 1194550-59-8 |
| Lifitegrast | 6-Benzofurancarboxylic acid | 77095-51-3 |
| Brinzolamide | 3-Acetyl-5-chloro-2-thiophenesulfonamide | 160982-10-5 |
| Brinzolamide | 3-(2-Bromoacetyl)-5-chloro-2-thiophenesulfonamide | 160982-11-6 |
| Brinzolamide | (S)-3,4-dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide | 160982-16-1 |
| Brinzolamide | (S)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-4-ol-6-sulfonamide-1,1- dioxide | 154127-42-1 |
| Montelukast Sodium | 3-Bromo-2,2-bis(bromomethyl)propanol / Pentaerythritol tribromide | 1522-92-5 |
| Montelukast Sodium | 3-bromo-2,2-bis(bromomethyl)propyl acetate | NA |
| Montelukast Sodium | 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid | 162515-68-6(B3) |
| Indacaterol | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | 312753-53-0 |
| Indacaterol | 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | 100331-89-3 |
| Indacaterol | (R)-8-(benzyl)-5-(oxiran-2-yl) quinolin-2(1H)-one | 173140-90-4 |
| Indacaterol | (R)-(+)-2-Methyl-CBS-oxazaborolidine | 112022-83-0 |
| Tezacaftor VX-661 | 2-Bromo-5-fluoro-4-nitroaniline | 952664-69-6 |
| Tezacaftor VX-661 | (R)-benzylglycolated-4-ammonium-2-bromo-5-fluoroaniline tosylate salt | 1294504-64-9 |
| Tezacaftor VX-661 | (S)-(2,2-Dimethyl-1,3-dioxolan-4-yl) methyl-4-methyl benzenesulfonate | 23735-43-5 |
| Tezacaftor VX-661 | (((2,2-dimethylbut-3-yn-1-yl)oxy)methyl)benzene | 1092536-54-3 (N-5) |
| Tezacaftor VX-661 | (R)-1-(5-Amino-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-1-yl)-3-(benzyloxy) propan-2-ol | 1294504-67-8 |
| Tezacaftor VX-661 | 2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-5-nitro-1H-indole | 1638771-94-4 |
| VenetoclaxABT-199 | 4-Fluoro-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzoic acid methyl ester | 1235865-75-4 |
| VenetoclaxABT-199 | methyl 2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-(piperazin-1-yl)benzoate | 1257044-57-7 |
| VenetoclaxABT-199 | 3-Nitro-4-[(oxan-4-ylmethyl)amino]benzene-1-sulfonamide | 1228779-96-1 |
| VenetoclaxABT-199 | 1-Piperazinecarboxylic acid, 4-[3-fluoro-4-(methoxycarbonyl)phenyl]-, 1,1-dimethylethyl ester | 1121599-68-5 |
| VenetoclaxABT-199 | 1-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazine dihydrochloride | 1628047-87-9 |
| VenetoclaxABT-199 | 1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine | 1228780-72-0 |
| VenetoclaxABT-199 | [2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methanol | 1228780-51-5 |
| VenetoclaxABT-199 | 5-Hydroxy-7-azaindole | 98549-88-3 |
| VenetoclaxABT-199 | 5-Bromo-7-azaindole | 183208-35-7 |
| Ibrutinib | Ethoxymethylenemalononitrile | 123-06-8 |
| Ibrutinib | 4-Aminopyrazolo[3,4-d]pyrimidine | 2380-63-4 |
| Ibrutinib | 4-Amino-3-iodopyrazolo[3,4-d]pyrimidine | 151266-23-8 |
| Ibrutinib | 3-Amino-1H-4-cyanopyrazole | 16617-46-2 |
| Ibrutinib | 3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine | 83255-86-1 |
| Upadacitinib ABT 494 | Upadacitinib | 1310726-60-3 |
| Upadacitinib ABT 494 | 3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1428243-26-8 |
| Upadacitinib ABT 494 | (3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester compd. with (alphaR)-alpha-methyl-1-naphthalenemethanamine (1:1) | 1428243-25-7 |
| Upadacitinib ABT 494 | 5-[(4-methylphenyl)sulfonyl]-5H-Pyrrolo[2,3-b]pyrazin-2-amine | 1201187-46-3 |
| Upadacitinib ABT 494 | tert-butyl (5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)carbamate | 1201187-44-1 |
| Temozolomide | Temozolomide | 85622-93-1 |
| Temozolomide | 5-Amino-4-imidazolecarboxamide (AICA) | 360-97-4 |
| Temozolomide | 4-Amino-5-imidazolecarboxamide hydrochloride (AICA HCl) | 72-40-2 |
| Gadobutrol | Gadobutrol | 138071-82-6 |
| Gadobutrol | Cyclen/1,4,7,10-Tetraazacyclododecane | 294-90-6 |
| Gadobutrol | 4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane | 57280-22-5 |
| Dapagliflozin Empagliflozin | 5-Bromo-2-chlorobenzoic acid | 21739-92-4 |
| Dapagliflozin Empagliflozin | 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether | 461432-23-5 |
| Dapagliflozin Empagliflozin | (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone | 461432-22-4 |
| Dapagliflozin Empagliflozin | (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan | 915095-89-5 |
| Dapagliflozin Empagliflozin | 2-(5-Bromo-2-fluorobenzyl)benzothiophene | 1034305-17-3 |
| Gliclazide | Gliclazide(API) | 21187-98-4 |
| Gliclazide | 4-Toluenesulfonylurea | 1694-06-0 |
| Gliclazide | Cyclopentane-1,2-dicarboximude | 5763-44-0 |
| Gliclazide | 3-Azabicyclo[3.3.0]octane hydrochloride | 112626-50-3 |
| Gliclazide | N-Amino-3-Azabicyclo[3,3,0]-Octan Hcl | 58108-05-7 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | 160844-75-7(F5) |
| Febuxostat | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2(F3) |
| Lurasidone Hydrochloride | (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione | 14805-29-9 |
| Lurasidone Hydrochloride | Cis-5-Norbornene-exo-2,3-dicarboxylic anhydride | 2746-19-2 |
| Lurasidone Hydrochloride | (1R,2R)-1,2-Cyclohexanedimethanol | 65376-05-8 |
| Lurasidone Hydrochloride | (1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid | 46022-05-3 |
| Lurasidone Hydrochloride | 4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl]piperazin-1-ium-1-sulfonate | 186204-37-5 |
